Skip to main content
Premium Trial:

Request an Annual Quote

Research Council of Norway Awards Genpoint $1.5M to Expand DNA Prep System

NEW YORK, March 3 (GenomeWeb News) - The Research Council of Norway has awarded Genpoint $1.5 million over three years to expand the company's Bugs 'n Beads DNA-preparation kit for use on additional microorganisms, the company said today.


The FUGE program contributed about $1 million to the company, while the PROSBIO program contributed the remainder. The FUGE acronym stands for "National Plan of Functional Genomics," while PROSBIO stands for "Innovation Program for the Process and Bio-medical Industry."


The company will expand its Beads 'n Bugs system, which isolates DNA from pathogenic bacteria in clinical samples and "other complex solutions," so that it can be isolated from Chlamydia and Mycoplasma, Genpoint said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more